Jean M. Panneton, MD
Back To Last Session: Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Tuesday, November 14, 2023 |
Presenter
With Acute Type B Aortic Intramural Hematomas (IMHs): When Is TEVAR Indicated: How Long Should Treatment Be Delayed For Optimal Outcomes: Earlier TEVAR Has More Adverse Events
11:48 AM - 11:53 AM
|
Presenter
Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears: It Promotes False Lumen Thrombosis, Aortic Remodeling And Improves Outcomes: How To Do It
5:50 PM - 5:55 PM
|
Presenter
Value And Limitations Of The iCast Balloon Expandable Covered Stent (From Getinge) Recently FDA Approved For Treating Iliac Artery Lesions
10:48 AM - 10:53 AM
|
Wednesday, November 15, 2023 |
Presenter
TEVAR For Acute Complicated TBAD: Improved Outcomes When The Endograft Is Extended To Zone 2 Versus Zone 3: Why Is This So And What To Do About The Subclavian Artery
4:08 PM - 4:13 PM
|
previous | next |